852 related articles for article (PubMed ID: 30593798)
21. Antigen presentation in celiac disease.
Qiao SW; Sollid LM; Blumberg RS
Curr Opin Immunol; 2009 Feb; 21(1):111-7. PubMed ID: 19342211
[TBL] [Abstract][Full Text] [Related]
22. Management of celiac disease in daily clinical practice.
Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D
Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262
[TBL] [Abstract][Full Text] [Related]
23. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
24. Celiac disease: how complicated can it get?
Tjon JM; van Bergen J; Koning F
Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
[TBL] [Abstract][Full Text] [Related]
25. Structural basis of T cell receptor specificity and cross-reactivity of two HLA-DQ2.5-restricted gluten epitopes in celiac disease.
Ciacchi L; Farenc C; Dahal-Koirala S; Petersen J; Sollid LM; Reid HH; Rossjohn J
J Biol Chem; 2022 Mar; 298(3):101619. PubMed ID: 35065967
[TBL] [Abstract][Full Text] [Related]
26. Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.
Huan J; Meza-Romero R; Mooney JL; Vandenbark AA; Offner H; Burrows GG
Mucosal Immunol; 2011 Jan; 4(1):112-20. PubMed ID: 20736999
[TBL] [Abstract][Full Text] [Related]
27. Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease.
Iversen R; Roy B; Stamnaes J; Høydahl LS; Hnida K; Neumann RS; Korponay-Szabó IR; Lundin KEA; Sollid LM
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15134-15139. PubMed ID: 31285344
[TBL] [Abstract][Full Text] [Related]
28. Discriminative T-cell receptor recognition of highly homologous HLA-DQ2-bound gluten epitopes.
Dahal-Koirala S; Ciacchi L; Petersen J; Risnes LF; Neumann RS; Christophersen A; Lundin KEA; Reid HH; Qiao SW; Rossjohn J; Sollid LM
J Biol Chem; 2019 Jan; 294(3):941-952. PubMed ID: 30455354
[TBL] [Abstract][Full Text] [Related]
29. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management.
Schuppan D; Dennis MD; Kelly CP
Nutr Clin Care; 2005; 8(2):54-69. PubMed ID: 16013224
[TBL] [Abstract][Full Text] [Related]
30. A high-affinity human TCR-like antibody detects celiac disease gluten peptide-MHC complexes and inhibits T cell activation.
Frick R; Høydahl LS; Petersen J; du Pré MF; Kumari S; Berntsen G; Dewan AE; Jeliazkov JR; Gunnarsen KS; Frigstad T; Vik ES; Llerena C; Lundin KEA; Yaqub S; Jahnsen J; Gray JJ; Rossjohn J; Sollid LM; Sandlie I; Løset GÅ
Sci Immunol; 2021 Aug; 6(62):. PubMed ID: 34417258
[TBL] [Abstract][Full Text] [Related]
31. Pathomechanisms in celiac disease.
Dieterich W; Esslinger B; Schuppan D
Int Arch Allergy Immunol; 2003 Oct; 132(2):98-108. PubMed ID: 14600421
[TBL] [Abstract][Full Text] [Related]
32. Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease.
Maglio M; Ziberna F; Aitoro R; Discepolo V; Lania G; Bassi V; Miele E; Not T; Troncone R; Auricchio R
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28934109
[TBL] [Abstract][Full Text] [Related]
33. Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum.
Montalvillo E; Bernardo D; Martínez-Abad B; Allegretti Y; Fernández-Salazar L; Calvo C; Chirdo FG; Garrote JA; Arranz E
Nutrients; 2015 Oct; 7(11):8960-76. PubMed ID: 26529008
[TBL] [Abstract][Full Text] [Related]
34. Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.
Sankari H; Hietikko M; Kurppa K; Kaukinen K; Mansikka E; Huhtala H; Laurila K; Reunala T; Hervonen K; Salmi T; Lindfors K
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069794
[TBL] [Abstract][Full Text] [Related]
35. HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: Implication for anti-gluten T cell response.
Pisapia L; Camarca A; Picascia S; Bassi V; Barba P; Del Pozzo G; Gianfrani C
J Autoimmun; 2016 Jun; 70():63-72. PubMed ID: 27083396
[TBL] [Abstract][Full Text] [Related]
36. HLA-DQ2-restricted T-cell recognition of gluten-derived peptides in celiac disease. Influence of amino acid substitutions in the membrane distal domain of DQ beta 1*0201.
Paulsen G; Lundin KE; Gjertsen HA; Hansen T; Sollid LM; Thorsby E
Hum Immunol; 1995 Feb; 42(2):145-53. PubMed ID: 7744618
[TBL] [Abstract][Full Text] [Related]
37. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
Koning F; Gilissen L; Wijmenga C
Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
[TBL] [Abstract][Full Text] [Related]
38. On the immune response to barley in celiac disease: Biased and public T-cell receptor usage to a barley unique and immunodominant gluten epitope.
Dahal-Koirala S; Neumann RS; Jahnsen J; Lundin KEA; Sollid LM
Eur J Immunol; 2020 Feb; 50(2):256-269. PubMed ID: 31628754
[TBL] [Abstract][Full Text] [Related]
39. Frequency of Gluten-Reactive T Cells in Active Celiac Lesions Estimated by Direct Cell Cloning.
Qiao SW; Dahal-Koirala S; Eggesbø LM; Lundin KEA; Sollid LM
Front Immunol; 2021; 12():646163. PubMed ID: 33796112
[TBL] [Abstract][Full Text] [Related]
40. T-cell and B-cell immunity in celiac disease.
du Pré MF; Sollid LM
Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):413-23. PubMed ID: 26060106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
